1. Academic Validation
  2. In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol

In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol

  • In Vitro Cell Dev Biol Anim. 2000 Feb;36(2):88-95. doi: 10.1290/1071-2690(2000)036<0088:IVTPOT>2.0.CO;2.
E Menegola 1 M L Broccia F Di Renzo M Prati E Giavini
Affiliations

Affiliation

  • 1 Department of Biology, University of Milan, Italy. tergia@imiucca.csi.unimi.it
Abstract

The teratogenic potential of two Antifungal triazoles (Triadimefon and Triadimenol) has been investigated in vitro by the rat postimplantation whole embryo culture method. Rat embryos 9.5 d old were cultured for 48 h in rat serum with Triadimefon (12.5-250 microM) or Triadimenol (6.25-125 microM) and then examined. Some embryos exposed to Triadimenol (6.25-125 microM) were cultured for 12 extra hours in control serum to improve their developmental degree and then immunostain cranial nerves and ganglia. The exposure to the highest doses of triazoles only moderately reduced some morphometrical developmental parameters. By contrast, 25-250 microM Triadimefon and 25-125 microM Triadimenol induced specific concentration-related teratogenic effects at the level of first and second branchial arches. After immunostaining, embryos exposed to 12.5-125 microM Triadimenol showed specific cranial nerve and ganglia abnormalities. The possible implication of neural crest cell alterations on triazole-related abnormalities is discussed.

Figures
Products